Public consultation on Evaluation of the quality, safety and efficacy of messenger RNA vaccines for the prevention of infectious diseases: regulatory considerations
The document on Evaluation of the quality, safety and efficacy of messenger RNA vaccines for the prevention of infectious diseases: regulatory considerations, is open for public comments on the WHO website: https://www.who.int/health-topics/biologicals#tab=tab_1 (scroll down to the right-hand you will find “Call for comments”.)
The direct link to the document is : https://cdn.who.int/media/docs/default-source/biologicals/call-for-comments/bs.2021.bs2402_who-regulatory-considerations-for-mrna-vaccines_final.pdf?sfvrsn=c8623b32_5.
Please use the WHO Comment Form to provide your comments: https://cdn.who.int/media/docs/default-source/biologicals/call-for-comments/comment_form_bs-2402_rna_2nd-pc_-9-july-2021-tz.doc?sfvrsn=65f0dc8d_5.
Comments should be sent to Dr. Tiequn Zhou at zhout@who.int no later than 17 September 2021.